Evaluation of Artifacts Associated with Macular Spectral-Domain Optical Coherence Tomography

Ophthalmology

Volumn 117, Issue 6, 2010, Pages

  Han, Ian C ^a   Jaffe, Glenn J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFACT; DIABETIC RETINOPATHY; DIAGNOSTIC ERROR; DISEASE SEVERITY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA FOVEA; RETINA IMAGE; RETINA MACULA EDEMA; UVEITIS;

EID: 77952892012     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.10.029     Document Type: Article

References (37)

1. Huang D., Swanson E.A., Lin C.P., et al. Optical coherence tomography. Science 254 (1991) 1178-1181
2. Ray R., Stinnett S.S., and Jaffe G.J. Evaluation of image artifact produced by optical coherence tomography of retinal pathology. Am J Ophthalmol 139 (2005) 18-29
3. Diabetic Retinopathy Clinical Research Network. Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology 114 (2007) 1520-1525
4. Browning D.J., Fraser C.M., and Propst B.W. The variation in optical coherence tomography-measured macular thickness in diabetic eyes without clinical macular edema. Am J Ophthalmol 145 (2008) 889-893
5. Ho J., Sull A.C., Vuong L.N., et al. Assessment of artifacts and reproducibility across spectral- and time-domain optical coherence tomography devices. Ophthalmology 116 (2009) 1960-1970
6. Forooghian F., Cukras C., Meyerle C.B., et al. Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci 49 (2008) 4290-4296
7. Apushkin M.A., Fishman G.A., and Janowicz M.J. Monitoring cystoid macular edema by optical coherence tomography in patients with retinitis pigmentosa. Ophthalmology 111 (2004) 1899-1904
8. Browning D.J., McOwen M.D., Bowen Jr. R.M., and O'Marah T.L. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology 111 (2004) 712-715
9. Garcia-Layana A., Salinas-Alaman A., Maldonado M.J., et al. Optical coherence tomography to monitor photodynamic therapy in pathological myopia. Br J Ophthalmol 90 (2006) 555-558
10. Krebs I., Binder S., Stolba U., et al. Choroidal neovascularization in pathologic myopia: three-year results after photodynamic therapy. Am J Ophthalmol 140 (2005) 416-425
11. Krebs I., Binder S., Stolba U., et al. Optical coherence tomography guided retreatment of photodynamic therapy. Br J Ophthalmol 89 (2005) 1184-1187
12. Larsson J., Zhu M., Sutter F., and Gillies M.C. Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Am J Ophthalmol 139 (2005) 802-806
13. Massin P., Duguid G., Erginay A., et al. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol 135 (2003) 169-177
14. Panozzo G., Gusson E., Parolini B., and Mercanti A. Role of OCT in the diagnosis and follow up of diabetic macular edema. Semin Ophthalmol 18 (2003) 74-81
15. Rivellese M., George A., Sulkes D., et al. Optical coherence tomography after laser photocoagulation for clinically significant macular edema. Ophthalmic Surg Lasers 31 (2000) 192-197
16. Sahni J., Stanga P., Wong D., and Harding S. Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study. Br J Ophthalmol 89 (2005) 316-320
17. Salinas-Alaman A., Garcia-Layana A., Maldonado M.J., et al. Using optical coherence tomography to monitor photodynamic therapy in age related macular degeneration. Am J Ophthalmol 140 (2005) 23-28
18. Browning D.J., and Fraser C.M. Regional patterns of sight-threatening diabetic macular edema. Am J Ophthalmol 140 (2005) 117-124
19. Hussain A., Hussain N., and Nutheti R. Comparison of mean macular thickness using optical coherence tomography and visual acuity in diabetic retinopathy. Clin Experiment Ophthalmol 33 (2005) 240-245
20. Hee M.R. Artifacts in optical coherence tomography topographic maps. Am J Ophthalmol 139 (2005) 154-155
21. Pons M.E., and Garcia-Valenzuela E. Redefining the limit of the outer retina in optical coherence tomography scans. Ophthalmology 112 (2005) 1079-1085
22. Sadda S.R., Wu Z., Walsh A.C., et al. Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology 113 (2006) 285-293
23. Somfai G.M., Salinas H.M., Puliafito C.A., and Fernandez D.C. Evaluation of potential image acquisition pitfalls during optical coherence tomography and their influence on retinal image segmentation. J Biomed Opt 12 (2007) 041209
24. Hee M.R., Puliafito C.A., Duker J.S., et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 105 (1998) 360-370
25. Hee M.R., Puliafito C.A., Wong C., et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 113 (1995) 1019-1029
26. Karam E.Z., Ramirez E., Arreaza P.L., and Morales-Stopello J. Optical coherence tomographic artefacts in diseases of the retinal pigment epithelium. Br J Ophthalmol 91 (2007) 1139-1142
27. Leung C.K., Chan W.M., Chong K.K., et al. Alignment artifacts in optical coherence tomography analyzed images. Ophthalmology 114 (2007) 263-270
28. Sadda S.R., Joeres S., Wu Z., et al. Error correction and quantitative subanalysis of optical coherence tomography data using computer-assisted grading. Invest Ophthalmol Vis Sci 48 (2007) 839-848
29. Chen T.C., Cense B., Pierce M.C., et al. Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging. Arch Ophthalmol 123 (2005) 1715-1720
30. Nassif N., Cense B., Park B.H., et al. In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. Opt Lett 29 (2004) 480-482
31. Mylonas G., Ahlers C., Malamos P., et al. Comparison of retinal thickness measurements and segmentation performance of four different spectral and time domain OCT devices in neovascular age-related macular degeneration. Br J Ophthalmol 93 (2009) 1453-1460
32. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103 (1985) 1796-1806
33. Wolf-Schnurrbusch U.E., Ceklic L., Brinkmann C.K., et al. Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci 50 (2009) 3432-3437
34. Leung C.K., Cheung C.Y., Weinreb R.N., et al. Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 49 (2008) 4893-4897
35. Patel P.J., Chen F.K., Ikeji F., et al. Repeatability of Stratus optical coherence tomography measures in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 49 (2008) 1084-1088
36. Lalwani G.A., Rosenfeld P.J., Fung A.E., et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 148 (2009) 43-58
37. Keane P.A., Chang K.T., Liakopoulos S., et al. Effect of ranibizumab retreatment frequency on neurosensory retinal volume in neovascular AMD. Retina 29 (2009) 592-600